Thursday, July 11, 2013
Rockwell Medical's iron deficiency drug succeeds in trial
(Reuters) - Rockwell Medical Inc said a late-stage trial of its experimental iron deficiency drug met the main goal of improving patients' hemoglobin levels.
The study was the first of two planned late-stage trials, and tested the drug, SFP, in adult patients with chronic kidney disease.
(Reporting by Esha Dey in Bangalore)
This entry passed through the Full-Text RSS service — if this is your content and you're reading it on someone else's site, please read the FAQ at fivefilters.org/content-only/faq.php#publishers. Five Filters recommends: 'You Say What You Like, Because They Like What You Say' - http://www.medialens.org/index.php/alerts/alert-archive/alerts-2013/731-you-say-what-you-like-because-they-like-what-you-say.html
